• Follow us
  • Holding BUMN Farmasi
  • For Healthcare Professional
  • Researcher
  • EN
    Flag IndonesiaID
    Flag EnglishEN
biofarma-logo-bumn biofarma-logo biofarma-logo-131 biofarma-logo-hashtag-only-case
  • Home
  • Who We Are

    About Us
    • Our Focus
    • Our Strategy
    • Our Distribution
    • Our Operations
    • Your Career
    Our Leadership
    • Corporate Executive Team
    • Management Team
    Our Achievement
    • Awards
    • Certification
    Sustainability
    • Our People
    • Access to Vaccine
    • Corporate Social Responsibility
    • Good Corporate Governance
    • Biodiversity
  • Product & Service

    Our Product
    • Combination Vaccine
    • Viral Vaccine
    • Bacterial Vaccine
    • Diagnostic Vaccine
    • Sera
    Our Health Service
    • Service of Industrial Micro Biology
    • Clinical Laboratory Service
    • Vaccination Service
    • Clinic & Pharmacy

    Visit our website

  • Media

    For Media
    • Latest News
    • Current Event
    Vaccine Fact
    Media Release
    FAQ
  • I Want to
search

Our Leadership Team

Bio Farma has more than 130 years of expertise and experience, with this long history, we are ready to continue to contribute to improving the quality of life of the nation in Indonesia and the world. We are trying to build vaccine sovereignty, self-reliance of raw materials, and support the Government's health programs. We lead efforts to build national research capabilities in the field of vaccines and Life Science.

  • Corporate Executive Team
  • Management Team
  • Board of Executives

    honestib-
    Honesti Basyir
    President Director See Profile
    honestib-

    Honesti Basyir

    President Director

    Indonesian citizen, domiciled in Jakarta. Born in Padang, June 24, 1968. Graduated as a Bachelor of Industrial Engineering at the Bandung Institute of Technology (ITB) and Masters degree in Corporate Finance from the Telkom Institute of Management. Previously, he held several strategic positions as President Commissioner of Metra, CMO Wholesale and International Business TLKM Group, and CEO of PT Kimia Farma, Tbk. The legal basis for the appointment as the President Director of Bio Farma is in accordance with the Decree of the Minister of SOEs number SK-203 / MBU / 09/2019 dated September 13, 2019, concerning Dismissal, Changes in Position Nomenclature, Transfer of Duties and Appointment of Members of the Board of Directors of a Limited Liability Company (Persero) PT. Bio Farma. Has no affiliation with other members of the Board of Directors, members of the Board of Commissioners or shareholders.

    leader-img-box-2
    M. Rahman Roestan
    Director of Operations See Profile
    leader-img-box-2

    M. Rahman Roestan

    Director of Operations

    Indonesian citizen, domiciled in Bandung. Born in Bandung on August 5, 1970. Graduated as a Bachelor of Pharmacy and Pharmacist from Padjadjaran University Bandung and Master of Business Administration (MBA) from ITB, has completed the Doctoral Program in Strategic Management at Padjadjaran University in 2016.

    Joined PT Bio Farma (Persero) since1998, has held various structural and strategic positions including as Head of Formulation, Packaging (2001-2004), Head of Quality Assurance System (2004-2006) and Head of Production Planning and Control Division (2006-2008), Corporate Secretary (2008-2017).

    The legal basis for the appointment as Director of Operations for Bio Farma is in accordance with the Decree of the Minister of SOEs number SK-203 / MBU / 09/2019 dated 13 September 2019, concerning Dismissal, Changes in Position Nomenclature, Transfer of Duties and Appointment of Members of the Board of Directors of a (Persero) PT. Bio Farma. From the beginning as Marketing Director then became President Director of PT Bio Farma (Persero) with a term of office continuing the remaining term of office based on the Decree of the Minister of BUMN Number: SK-127 / MBU / 07/2017 dated July 10, 2017. Since 2009 he has also served as a Management Representative for Integrated Management System ISO 9001, ISO 14001, OHSAS 18001. From 2016 until now, he has been active in the Indonesian Pharmaceutical Entrepreneurs Association, Government and Institutional Relations Committee. In 2010-2011 he was active in the Indonesian Quality Award Foundation (IQAF) as Examiner for Malcolm Baldridge Criteria for Excellence. In addition, he is active as a resource person and trainer in various forums at home and abroad, as well as actively writing several international journals. He is also active in organizations and plays a role both at national and international levels, 

    International level, Including :

    • 2014 – Presently Vice Chairman of Organization Islamic Cooperation)Vaccine Manufacturer Group (OIC - VMG)
    • 2012 to 2018 was involved as the Indonesian delegation for the International meeting in the field of Health at the World Health Assembly World Health Organization (WHO) Geneva
    • Indonesian Delegation for OIC Health Minister Conference Jeddah in 2013, 2015, 2017 ,2019

    National level, including :

    • Indonesian Pharmacists Association Central Board of Experts
    • Lecturer of Pharmacy Practitioner of UNPAD, Research Advisor School of Business and Mangament of ITB (SBM ITB).

    He has won several awards, including:

    • 2021  : Research Advisor Award from MBA ITB
    • 2020  : Padjadjaran Utama from Padjadjaran University
    • 2019  : Business Innovation and Green CEO from Warta Ekonomi
    • 2019  : Inspiring Leader of Change and Executive Figure from Indonesia Most Leading Award
    • 2019  :  Inspirational and Innovative Leader from 7Sky Media Award
    • 2018  :  Top Leader on IT Leadership from IT Works CEO

    He is also the author of Pharma 2030, Towards Increasing National Pharmaceutical Competitiveness

    Has no affiliation with other members of the Board of Directors, members of the Board of Commissioners or shareholders.

    leader-img-box-3
    Sri Harsi Teteki
    Director of Institutional Relations See Profile
    leader-img-box-3

    Sri Harsi Teteki

    Director of Institutional Relations

    Indonesian citizen, domiciled in Bandung. She was born in Yogyakarta on June 28, 1964. She received her Master of Health degree at the Faculty of Medicine, Diponegoro University (UNDIP) in 2003. Adjunct Health Insurance Expert (AAAK), December 27, 2007. She is active in the UNDIP Faculty of Medicine Alumni Association or Ika Medica, PAMJAKI and IDI. The legal basis for the appointment as Director of Institutional Relations of Bio Farma is in accordance with the Decree of the Minister of SOE Number SK-322/MBU/10/2021 concerning Changes in Position Nomenclature, Transfer of Tasks, and Appointment of Members of the Board of Directors of PT Bio Farma on October 1, 2021.  Prior to her current position, she served as Director of Marketing for Research & Development for Bio Farma is in accordance with the Decree of the Minister of BUMN number SK-15- / MBU / 05/2021 dated May 7, 2021 concerning Changes in the Nomenclature of Position and Transfer of Duties of Members of the Board of Directors of the Company (Persero) PT Bio Farma. Before she assumed her current position, she served as Director of Marketing, Research & Development I for Bio Farma, according to the Decree of the Minister of SOEs number SK-203 / MBU / 09/2019 dated September 13, 2019, concerning Dismissal, Changes in Position Nomenclature, Transfer of Tasks and Appointment of members of the Board of Directors of (Persero) PT Bio Farma. From the beginning as a Marketing Director based on the Decree of the Minister of State-Owned Enterprises number SK-27 / MBU / 01/2018 dated January 22, 2018, concerning the Transfer of Tasks and Appointment of Members of the Board of Directors of PT Bio Farma (Persero). Previously, she held several strategic positions as Director at TelkoMedika since 2013 and President Director of TelkoMedika (Metra-Yakes Group) from 2016 to January 22 2018. For more than 24 years he served in one of the State-Owned Enterprises, namely PT Telkom with occupied various positions. She also received the "Best Manager" award from PT TELKOM in 2007, and was active as a speaker in various national seminars, one of which discussed the National Health Insurance. Has no affiliation with other members of the Board of Directors, members of the Board of Commissioners or shareholders.

    pa harte new
    I.G.N Suharta Wijaya
    Director of Finance, Risk Management and Human Resources See Profile
    pa harte new

    I.G.N Suharta Wijaya

    Director of Finance, Risk Management and Human Resources

    Indonesian Citizen, domiciled in Jakarta. Born in Singaraja, 16 August 1967. Graduated as a Bachelor of Economics from the Padjadjaran University (S1) and obtained the Master’s degree in Management from the Bogor Institute of Agriculture. The legal basis for appointment as Director of Finance, Management of Risks and Human Resources of Bio Farma is pursuant to Decree of the Minister of SOE number SK-15-/MBU/05/2021 dated 7 May 2021 concerning Change of Position Nomenclature and Transfer of Duties of Members of the Board of Directors of the Company (Persero) PT Bio Farma. He previously served as Director of Finance, Business Partner under SK-203/MBU/09/2019 dated 13 September 2019 concerning Dismissal, Change of Position Nomenclature, Transfer of Duties and Appointment of Members of the Board of Directors of the Company (Persero) of PT Bio Farma. He previously held several strategic positions as Director of Commercial Operations of PTPN VIII, Director of PTPN III and Director of Finance of PT Kimia Farma, Tbk. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

    Soleh-Ayubi
    Soleh Ayubi, Ph.D
    Director of Transformation and Digital See Profile
    Soleh-Ayubi

    Soleh Ayubi, Ph.D

    Director of Transformation and Digital

    Indonesian Citizen, domiciled in Jakarta, born in Pemalang Central Java. Graduated from the Bachelor of Informatics Engineering Program in 2005, and then graduated from the Master of Science in Informatics Program in 2007, both were obtained from the Bandung Institute of Technology. Furthermore, Soleh continued his education and obtained the degree of Doctor of Philosophy (PhD) in Health Sciences from the University of Pittsburgh in 2012.

    The legal basis for appointment as Director of Transformation and Digital of Bio Farma is pursuant to Decree of the Minister of SOE number SK-15-/MBU/05/2021 dated 7 May 2021 concerning Change of Position Nomenclature and Transfer of Duties of Members of the Board of Directors of the Company (Persero) PT Bio Farma. Prior to holding his current position, he was appointed Director of Digital Healthcare of Bio Farma as of 24 August 2020 under Decree of the Minister of State Owned Enterprises Number: SK-203/MBU/09/2019 dated 24 September 2020 concerning Change of Position Nomenclature, Transfer of Duties and Appointment of Members of the Board of Directors of the Company (Persero) of PT Bio Farma.

    Prior to returning to Indonesia and joining Bio Farma, Soleh had 12 years of global experience in healthcare by joining several international companies; e.g.Novo Nordisk (Seattle, USA) as Director, Head of Digital Therapeutics and Data Science from 2019 - 2020; Unitedhealth Group (Boston, USA) as Director of Innovation, Research and Development from 2017 - 2019; Boston Children’s Hospital (Boston, USA) as Technical Innovation Manager from 2013 - 2016; Veterans Affairs Hospital (Pittsburgh, USA) as Senior Software Engineer from 2011 - 2012.

    Other than the health industry, Soleh Al Ayubi is also active in the education world and was appointed Digital and Health Entrepreneurship at Harvard University (Boston, USA) from 2017 to date, whose duty is to provide training and mentoring to medical students, students of the Doctoral (PhD) and post-doctoral programs at the Harvard Medical School. Since 2020, he also has become a Faculty Adjunct at the School of Business and Management, Bandung Institute of Technology.

    At the scientific and R & D community, other than holding 2 patents in the United States of America, Soleh is also active in various international conferences and publications in healthcare innovation and healthcare technology, either as a speaker, reviewer or journalist. As a writer, Soleh published 15 papers in international journals or proceedings. Not affiliated with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

    LinkedIn Profile: https://www.linkedin.com/in/ayubi

    ibu yuliana
    Yuliana Indriati
    Director of Research and Business Development See Profile
    ibu yuliana

    Yuliana Indriati

    Director of Research and Business Development

    Indonesian citizen, born in Jakarta on November 23, 1968. Obtained a Bachelor's degree in Pharmacy from Gadjah Mada University (UGM) Yogyakarta, and a pharmacist at the same university. Master's degree in Management was obtained from Prasetya Mulya University Jakarta. The legal basis for the appointment as Director of Research and Business Development is in accordance with the Decree of the Minister of SOE Number SK-322/MBU/10/2021 concerning Changes in Position Nomenclature, Transfer of Tasks, and Appointment of Members of the Board of Directors of the Company (Persero) PT Bio Farma on October 1, 2021. Prior to serving as Director of Research and Business Development of Bio Farma, She had joined several pharmaceutical companies in Indonesia and held strategic positions. Last position as Director – Licensing out and Regulatory Affairs PT Kalbe Genexine Biologics, Jakarta Has no affiliation with other members of the Board of Directors, members of the Board of Commissioners or shareholders.

  • Senior Executive Vice President (SEVP)

    leader-img-box-5
    Juliman
    SEVP Production See Profile
    leader-img-box-5

    Juliman

    SEVP Production

    Indonesian Citizen, domiciled in Bandung. He was born in Pangkalpinang on 23 September 1962. He obtained the degree of Bachelor of Pharmacy, Bandung Institute of Technology in 1988 and the degree of Apothecary in 1989 at the same alma mater and continued his study by taking the Master of Operations Management program at the Padjadjaran University and obtained the Master’s degree in 2005. The legal basis for appointment as Senior Executive Vice President (SEVP) Manufacturing is pursuant to Decree of the Board of Directors of PT Bio Farma (Persero) Number: KEP-05779/DIR/IX/2019 dated 16 September 2019. Previously serving as Director of Manufacturing for the first period pursuant to Decree of the Minister of SOE Number: SK-221/MBU/2013 dated 12 April 2013. In 10 July 2017, the Ministry of SOE as a shareholder issued a Decree Number: SK-127/MBU/07/2017 stipulated Juliman as Acting President Director of Bio Farma until the appointment of definitive President Director, i.e. 23 January 2018. He was reappointed as Director of Manufacturing for the second period pursuant to Decree of the Minister of SOE Number: SK – 101/MBU/04/2018 dated 20 April 2018. He previously held various structural and strategic positions as Head of Poliomyelitis and Measles Vaccine Support Department, Head of Measles Vaccine Manufacturing Department, Head of Engineering and Maintenance Division, Head of Export Marketing Division and Head of Logistics Division. His experience in the field of vaccine manufacturing and Good Manufacturing Practices (GMP) often made him an informant in seminar, interview and audience events. He is also often involved in various international level activities, namely being active as a Trainer in the WHO Global Training Network (GTN) on Quality Assurance of Live Attenuated Poliomyelitis and Measles Vaccines and part of the Indonesian delegates in attending the World Health Assembly Forum organized by the World Health Organization (WHO). He also actively attends the Annual General Meeting held by the DCVMN (Developing Countries Vaccines Manufacturer Network), i.e. developing countries vaccines manufacturer collaboration organization. He currently serves as member of the Alternate Board of GAVI (Global Alliance for Vaccine Immunization) representing the DCVMN Organization to attend the GAVI Board Meeting regularly held three times a year to discuss and decide on the policies taken by the GAVI Board related to the Global Immunization program. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

    leader-img-box-6
    Disril Revolin Putra
    SEVP Human Capital and Compliance See Profile
    leader-img-box-6

    Disril Revolin Putra

    SEVP Human Capital and Compliance

    Indonesian Citizen, domiciled in Jakarta. He was born in Tanjung Pinang, on 18 December 1965. Graduated as a Bachelor of Law from the Jakarta Islamic University (1989) and a Master of Law from the University of Indonesia (1998). The legal basis for appointment as Senior Executive Vice President (SEVP) Legal and Compliance is pursuant to Decree of the Board of Directors of PT Bio Farma (Persero) Number: KEP-05777/DIR/IX/2019 dated 16 September 2019. Joined PT Bio Farma (Persero) in 2017 and serving as Director of HR and General Affairs pursuant to Decree of the Minister of State Owned Enterprises number SK-131/MBU/07/2017 dated 14 July 2017. He previously served as Director of HR and Law at PT Pelindo II, from 16 May 2016 until 14 July 2017. More than twenty years in service at one of the State Owned Enterprises, i.e. PT Bank Negara Indonesia (Persero), he also served as Head of Legal Division (2011 - 2015) Jakarta Kota Regional Head (2015 - 2016), SEVP Network and Services (2016) and various other strategic positions. For the last several years, he has been entrusted with a functional position at several supervisory committees. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

    leader-img-box-7
    Adriansjah Azhari
    SEVP Research and Development See Profile
    leader-img-box-7

    Adriansjah Azhari

    SEVP Research and Development

    Indonesian Citizen, domiciled in Bandung.  He was born in Bloomington, Indiana, USA, on 5 September 1963, obtained the Bachelor of Pharmacy degree from the Bandung Institute of Technology in 1988, and obtained the Master of Operations Management degree from the Padjadjaran University in 2005. The legal basis for appointment as Senior Executive Vice President (SEVP) Research and Development is pursuant to Decree of the Board of Directors of PT Bio Farma (Persero) Number: KEP-05778/DIR/IX/2019 dated 16 September 2019. Previously serving as Director of Planning and Development pursuant to Decree of the Minister of SOE Number: SK – 101/MBU/04/2018. He has dedicated himself to Bio Farma since 1989 by occupying various strategic positions as Head of Business Planning and Strategy Division, Head of Quality Assurance Division; Apothecary In Charge of Quality, Head of Bacteria Vaccine Division and Head of Pharmaceutical Product Division. His experience in research made him involved in various international activities, such as the Developing Countries Vaccine Manufacturers’ Network (DCVMN), World Health Organisation (WHO) dan International Society for Pharmaceutical Engineering (ISPE). In addition, he is also active as an informant in various domestic and overseas activities, namely the Annual General Meeting of Developing Countries Vaccine Manufacturers’ Network (DCVMN), Rio de Janeiro, Brazil; World Health Organization (WHO) QC course on Hib vaccine, NVI, The Netherlands; ISPE Indonesian Affiliate annual conference 2012, Jakarta;  National Vaccine Research Forum, Jakarta; Rotavirus symposium, Bangkok, Thailand; Proteomic Avian Flu Vaccine Seminar, Avian Influenza Research Center (AIRC), Airlangga Univ, Surabaya; WHO briefing for manufacturers WHO prequalification programme” Beijing, China; Global Health Regulatory Meeting on PDPs organized by PATH, Hanoi, Vietnam, etc. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

  • Board of Commissioners

    circle-cropped
    Tanri Abeng
    President Commissioner See Profile
    circle-cropped

    Tanri Abeng

    President Commissioner

    Indonesian Citizen, born in Selayar, South Sulawesi, Indonesia, 7 March 1949. As of 31 December 2020, his age is 79 years old. Attended education at several domestic and overseas universities Faculty of Economics of Hasanudin University, Makassar, Master of Business Administration Program, University of New York Buffalo, Doctor, Multidisciplinary Science, University of Gadjah Mada. Previously occupying several important positions at several large companies, including SOE, such as President Commissioner of PT Telekom Komunikasi (2004 - 2010) and President Commissioner of Pertamina (2010 - 2019). He also occupied several prominent positions at the government, such as serving as Minister of SOE Utilization in the Development Cabinet VII and Development Reformation Cabinet. The legal basis for appointment of President Commissioner of Bio Farma is pursuant to the copy of Decree of the Minister of State Owned Enterprises as the General Meeting of Shareholders of the Company (Persero) PT Bio Farma Number SK-149/MUB/05/2021 concerning Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) PT Bio Farma dated 7 May 2021. Not affiliated with with other members of the Board of Directors, members of the Board of Commissioners or the shareholders.

    aviani
    Arianti Anaya
    Commissioner See Profile
    aviani

    Arianti Anaya

    Commissioner

    An Indonesian citizen, domiciled in Jakarta, she was born in Jakarta, on September 24. She completed her studies at the Faculty of Dentistry (FKG) University of Indonesia in 1988, and earned her Masters in Public Health from the University of Indonesia in 2005. 

    The legal basis for her appointment as the Board of Commissioners of PT Bio Farma (Persero) is based on the Decree of the Minister of SOE NUMBER: SK-70/MBU/03/2022 dated March 8, 2022. She serve as Director General of Health Personnel of the Indonesian Ministry of Health in 2021 has held several other strategic positions at the Ministry of Health, including Acting Director General of Pharmacy and Equipment Health, and Secretary of the Directorate General of Pharmaceuticals and Medical Devices since 2018, Director of Assessment of Medical Devices and Household Health Supplies in 2016, and Director of Production and Distribution of Medical Devices in 2012.

    She is also active in several National Cooperation activities including Member of the Working Group Medical Device Industry Development 2018 – now, Member of the Expert Team for Assessment of Medical Devices and PKRT 2018 – now.

    International Cooperation includes Steering Committee, WHO-SEARN (South East Asia Regulatory Network) | 2016 – present and Indonesia Head of Delegation in APEC-RHSC 2015 – 2019.

     

    BAPAK RONI DWI S
    Roni Dwi Susanto
    Commissioner See Profile
    BAPAK RONI DWI S

    Roni Dwi Susanto

    Commissioner

    Indonesian citizen, born on December 8, 1967. Graduated as a Bachelor of Economics and Agriculture from Bogor Agricultural University (IPB) in 1991. Obtained a Master's Degree in Planning and Public Policy from the University of Indonesia in 2000. Then obtained a Doctoral degree in the field of Agricultural Economics, from IPB in 2012. The legal basis for the appointment as the Board of Commissioners of PT Bio Farma (Persero) is based on the Decree of the Minister of BUMN Number: SK-323/MBU/10/2021 concerning Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) PT Bio Farma Date October 1, 2021. Currently he is still serving as Widyaswara Utama BAPPENAS since September 2021. He has no affiliation with other members of the Board of Directors, members of the Board of Commissioners or shareholders.

    leader-img-box-11
    Made Arya Wijaya
    Commissioner See Profile
    leader-img-box-11

    Made Arya Wijaya

    Commissioner

    Indonesian Citizen, domiciled in Jakarta. Born in Singaraja, on 17 August 1965. As of 31 December 2020, his age is 55 years old. Graduated as Diploma III, National College of Accounting, Jakarta (1987) and Bachelor of Economics, Jakarta Islamic University (1995), finished the Master of Science in Finance, University of Colorado at Denver, USA in 2001. The legal basis for appointment as Commissioner of Bio Farma is pursuant to Decree of the Minister of SOE Number: SK – 102/MBU/04/2018 dated 20 April 2018. He currently serves as Director of Budgeting Rule Harmonization, Directorate of Budgeting Rule Harmonization, Directorate General of Budget since November 2015 - current. He previously served as Acting Director of Budgeting Rule Harmonization, Directorate of Budgeting Rule Harmonization, Directorate General of Budget from September 2014 - November 2015, and served as Head of Sub Directorate of Budgeting System Development, Directorate of Budgeting System, Directorate General of Budget, 2008 - 2011. At the start of his career, he served as Implementation Officer at the Directorate of Miscellaneous Budget, Directorate General of Budget, 1988 - 1990 and as Implementation Coordinator at the Directorate of Miscellaneous Budget, Directorate General of Budget, 1990 - 1996. Not affiliated with other members of the Board of Directors and members of the Board of Directors or the shareholders.

    leader-img-box-13
    Ahmad Ramli
    Commissioner See Profile
    leader-img-box-13

    Ahmad Ramli

    Commissioner

    Prof. Dr. Ahmad M. Ramli,S.H.,M.H.,FCB.Arb. Born in Bandung on 4 July 1961, is a Professor of Cyber Law and Intellectual Property Law at the Padjadjaran University. He currently serves as Director General of Post and Informatics Operations, Ministry of Communications and Informatics of the Republic of Indonesia. Previous positions include the Director General of Intellectual Property, Head of National Law Development Agency (BPHN), and Acting Director General of Law and Legislation, Ministry of Law and Human Rights of the Republic of Indonesia. In the corporate world, he served as Commissioner at the SOE. In the Legislation Field, he was trusted to become the Government Team Chairman in discussing various Bills together with the House of Representatives of the Republic of Indonesia, such as: Copyright Bill, Trademark Bill, Patent Bill, Public Information Disclosure Bill, Money Laundering Bill, Information and Electronic Transaction Bill (as Deputy Chairman) etc., all of which were promulgated. In his Profession, he currently serves as member of the Expert Council of the Indonesian Association of Bachelor of Law (ISHI). He pursued higher education by finishing his S1, S2 programs and the Jurisprudence Doctoral Program (graduated cum laude) from the Padjadjaran University. Attended the Visiting Scholar Program at the University of California Berkeley, USA, and Certificate Program on Intellectual Property at the Japan Patent Office, Tokyo. For his commendable service to the country, in 2019 he was awarded the Satya Lencana Wirakarya by President Joko Widodo. In addition, he also received the Satya Lencana Karya Satya X, XX, and XXX Year award from the President of the Republic of Indonesia, and Satya Karya Bakti Pendidikan from the Rector of Padjadjaran University. At the Padjadjaran University, he served as Dead at the Faculty of Law. When he was a college student, he was recorded as Chairman of the Student Senate at the Faculty of Law, Padjadjaran University, and elected as First Exemplary student of the Padjadjaran University, and received the national award of Exemplary student from the Minister of Education and Culture of the Republic of Indonesia. Not affiliated with other members of the Board of Directors and members of the Board of Directors or the shareholders.

    circle-cropped(2)
    Nizar Yamanie
    Independent Commissioner See Profile
    circle-cropped(2)

    Nizar Yamanie

    Independent Commissioner

    Indonesian Citizen, born in Surabaya, 23 December 1952. As of 31 December 2020, his age is 68 years old. Finished S1 education at the Faculty of Medicines, Airlangga University in 1982. Continued his education to the Oxford University, Oxford England from 1991 - 1992. Later in 1994, finished his education as Neurologist at the Faculty of Medicines, University of Indonesia. Later in 2003, finished his education as Consultant in the field of Neurology. He occupied several strategic positions, namely as Member of the Board of Commissioners of PT Indofarma, Tbk from 2018 - 2019. Member of the Board of Commissioners of PT Surveyor Carbon Consulting from 2011 - 2015, Member of the Board of Commissioners of Sanglah Bali Hospital from 2011 - 2016, and also served as Member of the Board of Commissioners of PT Bio Farma (Persero) from 2012 - 2016.  The legal basis for appointment of President Commissioner of Bio Farma is pursuant to the Copy of Decree of the Minister of State Owned Enterprises As the General Meeting of Shareholders of the Company (Persero) of PT Bio Farma Number: SK-149/MUB/05/2021 concerning Dismissal and Appointment of Members of the Board of Commissioners of the Company (Persero) of PT Bio Farma dated 7 May 2021. Not affiliated with other members of the Board of Directors and members of the Board of Directors or the shareholders.

Head Office
Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
No. Telp
+62 22-2033755
Fax
+62 22 - 2041306
Bio Care
1500810
Email
mail@biofarma.co.id
website
www.biofarma.co.id
Digital Healthcare Office Jakarta Lt. 26
Equity Tower Sudirman Central Business District (SCBD) Lot 9
Jl. Jend. Sudirman Kav. 52-53
Jakarta Selatan 12190, Indonesia
Information
  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career
 
  • Contact Us
  • E-PPID
  • Announcement
  • I Want to
  • Media Release
Our Partner

Quick Links
  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2022. All Rights Reserved by Bio Farma
Holding BUMN Farmasi
For Healthcare Professional
Researcher

Change Language

EN
  • Home
  • Who We Are
    • About Us
      • About Us
      • Our Focus
      • Our Strategy
      • Our Distribution
      • Our Operations
      • Your Career
    • Our Leadership
      • Corporate Executive Team
      • Management Team
    • Our Achievement
      • Awards
      • Certification
    • Sustainability
      • Our People
      • Access to Vaccine
      • Corporate Social Responsibility
      • Good Corporate Governance
      • Biodiversity
  • Product & Service
    • Our Product
      • Our Product
      • Combination Vaccine
      • Viral Vaccine
      • Bacterial Vaccine
      • Diagnostic Vaccine
      • Sera
    • Our Health Service
      • Our Health Service
      • Service of Industrial Micro Biology
      • Clinical Laboratory Service
      • Vaccination Service
      • Clinic & Pharmacy
  • Media
    • For Media
      • For Media
      • Latest News
      • Current Event
    • Vaccine Fact
    • Media Release
    • FAQ
  • I Want to
  • Follow us
Change Language
  • Flag IndonesiaID
  • Flag EnglishEN
BIO CARE 1500810 icon-phone
Youtube icon-youtube
Corporate Reporting icon-statistics